| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Minireview |
Division of Reproductive Biology, Department of Obstetrics and Gynecology, Stanford University School of Medicine, Stanford, California 94305-5317
Address all correspondence and requests for reprints to: Aaron J. W. Hsueh, Division of Reproductive Biology, Department of Obstetrics and Gynecology, Stanford University School of Medicine, Stanford, California 94305-5317. E-mail: aaron.hsueh{at}stanford.edu.
TGF-ß family proteins with a cystine knot motif serve as ligands for diverse families of plasma membrane receptors. Bone morphogenetic protein (BMP) antagonists represent a subgroup of these proteins, some of which bind BMPs and antagonize their actions during development and morphogenesis. Availability of completed genome sequences from diverse organisms allows bioinformatic analysis of the evolution of BMP antagonists and facilitates their classification. Using a regular expression algorithm (http://BioRegEx.stanford.edu), an exhaustive search of the human genome identified all cystine knot-containing BMP antagonists. Based on the size of the cystine ring, these proteins were divided into three subfamilies: CAN (eight-membered ring), twisted gastrulation (nine-membered ring), as well as chordin and noggin (10-membered ring). The CAN family can be divided further into four subgroups based on a conserved arrangement of additional cysteine residuesgremlin and PRDC, cerberus and coco, and DAN, together with USAG-1 and sclerostin. We searched for orthologs of human BMP antagonists in the genomes of model organisms and analyzed their phylogenetic relationship. New human paralogs were identified together with the verification of orthologous relationships of known genes. We also discuss the physiological roles of the CAN subfamily of BMP antagonists and the associated genetic defects. Based on the known three-dimensional structure of key cystine knot proteins, we postulated disulfide bondings for eight-membered ring BMP antagonists to predict their potential folding and dimerization.
This article has been cited by other articles:
![]() |
D. Umulis, M. B. O'Connor, and S. S. Blair The extracellular regulation of bone morphogenetic protein signaling Development, November 15, 2009; 136(22): 3715 - 3728. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Galet, F. Guillou, F. Foulon-Gauze, Y. Combarnous, and M. Chopineau The {beta}104-109 sequence is essential for the secretion of correctly folded single-chain {beta}{alpha} horse LH/CG and for its FSH activity J. Endocrinol., October 1, 2009; 203(1): 167 - 174. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. B. Lintern, S. Guidato, A. Rowe, J. W. Saldanha, and N. Itasaki Characterization of Wise Protein and Its Molecular Mechanism to Interact with both Wnt and BMP Signals J. Biol. Chem., August 21, 2009; 284(34): 23159 - 23168. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. L. Trudeau Really Old Hormones Up to New Tricks: Glycoprotein Hormone Subunits May Have Roles in Development Endocrinology, August 1, 2009; 150(8): 3446 - 3447. [Full Text] [PDF] |
||||
![]() |
S. Dos Santos, C. Bardet, S. Bertrand, H. Escriva, D. Habert, and B. Querat Distinct Expression Patterns of Glycoprotein Hormone-{alpha}2 and -{beta}5 in a Basal Chordate Suggest Independent Developmental Functions Endocrinology, August 1, 2009; 150(8): 3815 - 3822. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Veverka, A. J. Henry, P. M. Slocombe, A. Ventom, B. Mulloy, F. W. Muskett, M. Muzylak, K. Greenslade, A. Moore, L. Zhang, et al. Characterization of the Structural Features and Interactions of Sclerostin: MOLECULAR INSIGHT INTO A KEY REGULATOR OF Wnt-MEDIATED BONE FORMATION J. Biol. Chem., April 17, 2009; 284(16): 10890 - 10900. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. K. Samson, J. V. Zhang, O. Avsian-Kretchmer, K. Cui, G. L. C. Yosten, C. Klein, R.-M. Lyu, Y. X. Wang, X. Q. Chen, J. Yang, et al. Neuronostatin Encoded by the Somatostatin Gene Regulates Neuronal, Cardiovascular, and Metabolic Functions J. Biol. Chem., November 14, 2008; 283(46): 31949 - 31959. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. R. Blish, W. Wang, M. C. Willingham, W. Du, C. E. Birse, S. R. Krishnan, J. C. Brown, G. A. Hawkins, A. J. Garvin, R. B. D'Agostino Jr., et al. A Human Bone Morphogenetic Protein Antagonist Is Down-Regulated in Renal Cancer Mol. Biol. Cell, February 1, 2008; 19(2): 457 - 464. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. t. Dijke, C. Krause, D. J. J. de Gorter, C. W.G.M. Lowik, and R. L. van Bezooijen Osteocyte-Derived Sclerostin Inhibits Bone Formation: Its Role in Bone Morphogenetic Protein and Wnt Signaling J. Bone Joint Surg. Am., February 1, 2008; 90(Supplement_1): 31 - 35. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Kassai, P. Munne, Y. Hotta, E. Penttila, K. Kavanagh, N. Ohbayashi, S. Takada, I. Thesleff, J. Jernvall, and N. Itoh Regulation of Mammalian Tooth Cusp Patterning by Ectodin Science, September 23, 2005; 309(5743): 2067 - 2070. [Abstract] [Full Text] [PDF] |
||||
![]() |
C.-W. Luo, E. M. Dewey, S. Sudo, J. Ewer, S. Y. Hsu, H.-W. Honegger, and A. J. W. Hsueh Bursicon, the insect cuticle-hardening hormone, is a heterodimeric cystine knot protein that activates G protein-coupled receptor LGR2 PNAS, February 22, 2005; 102(8): 2820 - 2825. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. A. Pangas, C. J. Jorgez, and M. M. Matzuk Growth Differentiation Factor 9 Regulates Expression of the Bone Morphogenetic Protein Antagonist Gremlin J. Biol. Chem., July 30, 2004; 279(31): 32281 - 32286. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |